View Author
transition group disease prevalence study virus state probability newborn mopv 1 transition probabilities mutation proportion health weight group b cancer challenge number birth model polioviru birth dose challenge dose ad p 1 prevalence proportions table diabetes estimate figure p 1 virus vaccine region individual problem vp 1 region population factor vaccination vp 1 regions antigenic ratio method example co-occurrence p-spline survey result seroconversion sabin stroke transportation problem signi ficantly risk factors strain people intervention topv study group sequence nonsynonymou signi titer cost matrix transportation netherland function multimorbidity state j virol disturbance replication 28 days residue 99 multinomial difference transition probability matrices residue matrix 10.5 interval
3 Most Recent Publications
|
Estimating net transition probabilities from cross-sectional data with application to risk factors in chronic disease modeling
(Article)
Kassteele, J. van de Hoogenveen, R.T. Engelfriet, P.M. Baal, P.H.M. van Boshuizen, H.C. |
2012-03-15
|
|
Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: Quantifying age patterns in the Dutch population using health survey data
(Article)
Baal, P.H.M. van Engelfriet, P.M. Boshuizen, H.C. Kassteele, J. van de Schellevis, F.G. Hoogenveen, R.T. |
2011-09-01
|
|
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine
(Article)
Sanden, S.M.G. van der Pallansch, M.A. Kassteele, J. van de El-Sayed, N. Sutter, R.W. Koopmans, M.P.G. Avoort, H.G.A.M. van der |
2009-09-22
|
